News and Announcements
Allowance of Phylogica’s US Patent for Synthetic Phylomer Libraries
- Published October 02, 2013 12:14PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
- US Patent allowed for rationally designed synthetic Phylomer libraries
- Broad applications of synthetic Phylomer libraries in therapeutics and diagnostics
- Patent allowance further secures Phylogica’s ownership of the entire Phylomer peptide class
- New patent greatly extends life of Phylogica’s core patent estate – out to November 2027
- Phylogica is already in discussion with prospective partners interested in accessing this technology
PERTH, AUSTRALIA: October 2nd, 2013 – Phylogica Ltd (ASX: PYC, XETRA: PH7) a leading Australian peptide drug discovery company, announces the allowance of its US patent application for synthetic Phylomer libraries. This core patent (designated USSN 11/672,419) covers generic methods of designing synthetic Phylomer peptide libraries based on the identification of parts of natural proteins, which are predicted to form structures independently when isolated from the parent protein from which they are derived. The patent also contains methods for maximising the diversity of such structures represented in the library.
To read the full ASX Release please click on the document below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
